Loading...
•
Dec 31, 2020
Waters Q4 2020 Earnings Report
Waters Q4 2020 financial results were reported, highlighted by sales growth and increased EPS.
Key Takeaways
Waters Corporation reported Q4 2020 sales of $787 million, a 10% increase as reported. GAAP EPS increased to $3.49, and non-GAAP EPS increased to $3.65. Adjusted free cash flow was strong at $240 million, a 52% increase from the prior year. Growth was led by strong performance in pharmaceutical and industrial end markets, with continued broad-based sales growth across all major geographies.
Sales of $787 million grew 10% as reported and 7% in constant currency.
GAAP EPS of $3.49; non-GAAP EPS of $3.65, a 14% increase from prior year.
Strong adjusted free cash flow of $240 million, a 52% increase from prior year.
Growth led by strong performance in pharmaceutical and industrial end markets.
Waters
Waters
Waters Revenue by Segment
Waters Revenue by Geographic Location
Revenue by Segment
Waters Instrument Systems Revenue
CapyFin.comTA Instrument Systems Revenue
CapyFin.comRevenue by Geographic Location
Asia Revenue
CapyFin.comAmericas Revenue
CapyFin.comEurope Revenue
CapyFin.com Forward Guidance
The Company expects full-year 2021 constant-currency sales growth in the range of 5% to 8%. Currency translation is expected to increase full-year sales growth by one to two percentage points. The Company also expects full-year 2021 non-GAAP EPS in the range of $9.32 to $9.57.
Revenue & Expenses
Visualization of income flow from segment revenue to net income